These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4718678)

  • 1. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract]   [Full Text] [Related]  

  • 5. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 6. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 8. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo effects of methotrexate. Inhibition of DNA synthesis and cell death in sensitive and resistant L1210 ascites populations.
    Hofer KG
    Chemotherapy; 1972; 17(1):59-70. PubMed ID: 5009468
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
    Thayer PS; Himmelfarb P; Roberts D
    Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo.
    Chello PL; Sirotnak FM; Dorick DM
    Cancer Res; 1979 Jun; 39(6 Pt 1):2106-12. PubMed ID: 445407
    [No Abstract]   [Full Text] [Related]  

  • 14. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporation of iododeoxyuridine-125-I into the DNA of L1210 leukemia cells during tumor development.
    Her KG; Hughes WL
    Cancer Res; 1970 Jan; 30(1):236-43. PubMed ID: 5458962
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
    Kawai M; Hillcoat BL
    Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
    Capizzi RL; Summers WP; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
    Chang BK; Huang AT; Joines WT
    Cancer Res; 1980 Apr; 40(4):1002-5. PubMed ID: 7357530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.